sulfamethoxazole has been researched along with Benign Meningeal Neoplasms in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaynon, PS | 1 |
| Steinherz, PG | 1 |
| Bleyer, WA | 1 |
| Ablin, AR | 1 |
| Albo, VC | 1 |
| Finklestein, JZ | 1 |
| Grossman, NJ | 1 |
| Littman, PS | 1 |
| Novak, LT | 1 |
| Pyesmany, AF | 1 |
1 trial available for sulfamethoxazole and Benign Meningeal Neoplasms
| Article | Year |
|---|---|
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined | 1988 |